# Treating Anorectal Dysfunction in MS

> **NCT02609607** · PHASE2 · TERMINATED · sponsor: **David Levinthal** · enrollment: 11 (actual)

## Conditions studied

- Constipation
- Fecal Incontinence
- Multiple Sclerosis

## Interventions

- **DRUG:** Bisacodyl
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02609607
- **Lead sponsor:** David Levinthal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2018-11
- **Final completion:** 2018-12
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Poor enrollment; funding ending Dec 31, 2018.
- **Last updated:** 2020-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02609607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02609607, "Treating Anorectal Dysfunction in MS". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02609607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*